Considering the biopharmaceutical industry's promising development over the next few years, he has invested 600 million to gradually acquire a 1.482% share in Lilly Company from the stock market.
Lilly Company mainly develops drugs for heart disease, diabetes, and weight loss, and their brands include Humalog, Zyprexa, Prozac, Cymbalta, Cialis, Strattera, Trulicity, Basaglar, Evista, and others.
The current stock price is 42 US Dollars, with a market value of 405 billion US Dollars.
After the global flu scare, the market value soared past one trillion, making it the first pharmaceutical company in the world to break the trillion-dollar market cap.
Additionally, the company's annual profits are quite substantial, with a higher and more stable dividend payout than that of Coca-Cola.
Investing now is extremely cost-effective.
